ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 107 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,157,823 | -96.9% | 57,718 | -95.6% | 0.00% | -100.0% |
| Q2 2023 | $37,277,681 | +68.0% | 1,321,435 | +2.4% | 0.02% | +50.0% |
| Q1 2023 | $22,193,091 | -19.3% | 1,290,296 | -5.5% | 0.01% | -16.7% |
| Q4 2022 | $27,501,130 | -4.7% | 1,365,498 | +2.5% | 0.01% | -14.3% |
| Q3 2022 | $28,849,000 | -24.2% | 1,331,884 | -1.7% | 0.01% | -17.6% |
| Q2 2022 | $38,060,000 | -17.2% | 1,354,463 | +35.9% | 0.02% | -5.6% |
| Q1 2022 | $45,990,000 | -41.0% | 996,759 | +7.5% | 0.02% | -35.7% |
| Q4 2021 | $77,918,000 | +18.6% | 926,937 | -6.0% | 0.03% | +7.7% |
| Q3 2021 | $65,704,000 | +31.3% | 985,953 | +4.8% | 0.03% | +30.0% |
| Q2 2021 | $50,052,000 | +4.4% | 940,828 | -14.9% | 0.02% | -4.8% |
| Q1 2021 | $47,958,000 | +10.7% | 1,105,282 | +32.5% | 0.02% | +5.0% |
| Q4 2020 | $43,341,000 | +72.0% | 834,448 | +8.3% | 0.02% | +42.9% |
| Q3 2020 | $25,196,000 | +5.3% | 770,770 | +54.7% | 0.01% | 0.0% |
| Q2 2020 | $23,927,000 | – | 498,272 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |